Invivyd (IVVD) Consolidated Net Income (2021 - 2025)

Invivyd (IVVD) posted Consolidated Net Income of -$12.2 million for Q4 2025, down 3.33% on a QoQ basis from -$11.8 million in Q3 2025, and up 33.93% year-over-year from -$9.1 million in Q4 2024.

Invivyd (IVVD) Consolidated Net Income (2021 - 2025) Analysis & Trends

Invivyd's Consolidated Net Income history runs 5 years deep, the most recent figure standing at -$12.2 million for Q4 2025.

  • Quarterly Consolidated Net Income rose 33.93% year-over-year to -$12.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$56.6 million (up 73.07% YoY) and the FY2025 annual result came in at -$307.8 million, up 26.95% from the prior year.
  • Consolidated Net Income was -$12.2 million for Q4 2025 at Invivyd, down from -$11.8 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at -$11.8 million in Q3 2025 and bottomed at -$647.2 million in Q3 2021.
  • A 5-year average of -$82.3 million and a median of -$51.6 million in 2022 frame the typical range for Consolidated Net Income.
  • Peak annual rise in Consolidated Net Income reached 91.74% in 2022, while the deepest fall reached 186.87% in 2022.
  • Invivyd's Consolidated Net Income stood at -$83.3 million in 2021, then soared by 41.88% to -$48.4 million in 2022, then tumbled by 57.51% to -$76.3 million in 2023, then jumped by 75.71% to -$18.5 million in 2024, then soared by 33.93% to -$12.2 million in 2025.
  • Business Quant data shows IVVD's Consolidated Net Income at -$12.2 million in Q4 2025, -$11.8 million in Q3 2025, and -$15.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn - -37.09 Mn
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,015.37 Bn 1,015.37 Bn - -14.46 Mn
4 BeOne Medicines 471.39 Bn 466.59 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 122.52 Bn 115.28 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 70.33 Bn 61.58 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 62.74 Bn 62.74 Bn - -26.94 Mn
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn 362.00 Mn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn 205.99 Mn
10 Invivyd 105.10 Mn -121.59 Mn 16.07 Mn -12.24 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -12.24 Mn
Sep 30, 2025 -11.85 Mn
Jun 30, 2025 -15.42 Mn
Mar 31, 2025 -17.12 Mn
Dec 31, 2024 -18.53 Mn
Sep 30, 2024 -62.75 Mn
Jun 30, 2024 -49.68 Mn
Mar 31, 2024 -79.34 Mn
Dec 31, 2023 -76.26 Mn
Sep 30, 2023 -45.04 Mn
Jun 30, 2023 -54.31 Mn
Mar 31, 2023 -39.78 Mn
Dec 31, 2022 -48.41 Mn
Sep 30, 2022 -53.46 Mn
Jun 30, 2022 -58.72 Mn
Mar 31, 2022 -111.33 Mn
Dec 31, 2021 -83.29 Mn
Sep 30, 2021 -647.18 Mn
Jun 30, 2021 -122.23 Mn
Mar 31, 2021 -38.81 Mn